Coinbase Tokenized Stocks Top $4B in Base DEX Trading

Coinbase tokenized stocks have surpassed $4 billion in cumulative decentralised exchange (DEX) trading volume on Base, according to the latest figures. Volume grew from tens of millions of dollars after launch on August 24, 2026, to more than $1 billion by mid-September, $2.26 billion by October 11 and over $3 billion by October 19. Coinbase also reported $1.5 billion in Base DEX trading over a 30-day period, up 313% from the previous 30 days. More than $260 million of Coinbase tokenized stocks is now deployed in Base DeFi protocols, up from about $14.66 million at the start of 2026. The tokens represent fractional shares in companies such as Apple and Nvidia, and can be traded on decentralised exchanges or used as loan collateral. Aerodrome accounted for 76% to 98% of trading during key periods, while Aave was among the protocols receiving deposits. The activity points to growing use of Base-based markets and on-chain equities, but does not establish increased demand for Coinbase shares or crypto assets more broadly. The tokens are described as backed one-for-one by shares held in regulated custody, but are available only to eligible non-US users, with the custody arrangement regulated in Abu Dhabi. These access and jurisdiction limits remain relevant risks for traders.
Neutral
The figures indicate rising activity in Coinbase tokenized stocks, Base DEXs and DeFi, but they do not show a direct price catalyst for a specific cryptocurrency. Higher trading volume and collateral deposits may support sentiment around Base’s ecosystem and on-chain finance in the short term. However, Base has no associated native token identified in the reports, and the activity does not establish increased demand for Coinbase shares or crypto assets more broadly. Aerodrome and Aave may see greater platform use, but volume alone does not guarantee sustained token demand or price gains. In the longer term, the restricted user base, custody and jurisdiction arrangements, and broader regulatory uncertainty could limit adoption. On the evidence provided, the expected impact on the price of a mentioned cryptocurrency is neutral.